NCT05073666View on ClinicalTrials.gov

Prevalence and Risk Factors of Chronic Thrombo-embolic Disease After a Pulmonary Embolism Event

CompletedOBSERVATIONAL
Enrollment

123

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

February 3, 2023

Study Completion Date

February 3, 2023

Conditions
Chronic Emboilism
Interventions
OTHER

NO INTERVENTION

NO INTERVENTION

Trial Locations (1)

06000

Nice University Hospital, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT05073666 - Prevalence and Risk Factors of Chronic Thrombo-embolic Disease After a Pulmonary Embolism Event | Biotech Hunter | Biotech Hunter